Pfizer will part ways with more than 200 employees across Switzerland as part of a continuing effort to slow its cash burn, according to a report from Bloomberg on Dec. 10. After the layoffs, the pharma expects its Switzerland headcount to shrink to around 70 people, down from 300, the publication noted, citing anonymous sources familiar with the matter.
All entries for: Layoffs
December 12, 2025
Pfizer
Layoffs
New York, NY
50,001+ employees
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule
November 25, 2025
Novartis
Layoffs
Basel, Switzerland
10,001-50,000 employees
Novartis will cut 550 full-time jobs at a facility in Switzerland by the end of 2027. The cuts come as the pharma company is ending production of tablets, capsules, and sterile medicine packaging at a plant in Stein, Switzerland.
Disease Area: Cardiology, Hematology, Immune Diseases, Multiple, Oncology
Drug Type: Biologic, Small Molecule
November 21, 2025
Nurix Therapeutic
Layoffs
Brisbane, CA
201-500 employees
Nurix Therapeutics is laying off an undisclosed number of employees.
Disease Area: Chronic Disease, Immune Diseases, Oncology
Drug Type: Small Molecule
November 20, 2025
Ensoma
Layoffs
Boston, MA
51-200 employees
As it transitions into a clinical-stage company, genetic therapy startup Ensoma is leaving behind half of its employees. CEO Jim Burns confirmed to Endpoints News that only 37 workers will remain with the company.
Disease Area: Rare Diseases
Drug Type: Biologic
November 20, 2025
AbbVieÂ
Layoffs
North Chicago, IL
50,001+ employees
AbbVie is laying off 59 employees across three California sites, effective Jan. 9, according to a Worker Adjustment and Retraining Notification (WARN) Act notice filed Nov. 13. AbbVie will permanently close the Dublin and Livermore sites after Jan. 9.
Disease Area: Oncology
Drug Type: Biologic
November 18, 2025
Merck
Layoffs
Rahway, NJ
10,001-50,000 employees
Merck is letting go of 204 employees from its Rahway, New Jersey location, continuing its aggressive layoff spree in recent months.
Disease Area: Antiviral, Cardiology, Immune Diseases, Multiple, Neurological Diseases, Oncology
Drug Type: Biologic, Small Molecule
November 17, 2025
Bristol Myers Squibb
Layoffs
Lawrenceville, NJ
10,001-50,000 employees
Bristol Myers Squibb has announced another round of layoffs, affecting 110 employees at the Lawrence Township site.
Disease Area: Cardiology, Hematology, Immune Diseases, Neurological Diseases, Oncology
Drug Type: Biologic, Small Molecule
November 14, 2025
Blueprint Medicines
Layoffs
Cambridge, MA
501-1,000 employees
An undisclosed number of employees at Blueprint Medicines will lose their jobs.
Disease Area: Immune Diseases, Oncology, Rare Diseases
Drug Type: Biologic
November 14, 2025
Gilead Sciences - Oceanside
Layoffs
Oceanside, CA
10,001-50,000 employees
Gilead Sciences laid off 17 people, having now let go of 53 people at the site.
Disease Area: Antiviral, Chronic Disease, Multiple, Oncology
Drug Type: Biologic, Small Molecule
October 30, 2025
Genentech
Layoffs
San Francisco, CA
10,001-50,000 employees
Genentech is laying off employees at its South San Francisco headquarters. According to a Worker Adjustment and Retraining Notification (WARN) Act notice, 118 staffers will lose their jobs effective Nov. 28.
Disease Area: Cardiology, Hematology, Immune Diseases, Neurological Diseases, Oncology
Drug Type: Biologic, Small Molecule